跳转至内容
Merck
CN

382113

Sigma-Aldrich

C646

≥99% (sum of isomers, HPLC), solid, histone acetyltransferase p300 inhibitor, Calbiochem®

别名:

组蛋白乙酰转移酶p300抑制剂,C646, 4-(4-{[5-(4,5-二甲基-2-硝基苯基)呋喃-2-基]亚甲基}-3-methyl-5-氧代-4,5-二氢-1H-吡唑-1-氧)苯甲酸,p300/CBP抑制剂IV,组蛋白乙酰转移酶抑制剂V,HAT抑制剂V

登录查看公司和协议定价

关于此项目

经验公式(希尔记法):
C24H19N3O6
CAS Number:
分子量:
445.42
MDL编号:
UNSPSC代码:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Product Name

组蛋白乙酰转移酶p300抑制剂,C646, Histone Acetyltransferase p300 Inhibitor, C646, CAS 328968-36-1, is a cell-permeable, reversible inhibitor of p300/CBP HAT (Ki = 400 nM). Competes with acetyl-CoA for the p300 Lys-CoA binding pocket.

质量水平

方案

≥99% (sum of isomers, HPLC)

表单

solid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
protect from light

颜色

brick red

溶解性

DMSO: 50 mg/mL

运输

ambient

储存温度

−20°C

InChI

1S/C24H19N3O6/c1-13-10-20(21(27(31)32)11-14(13)2)22-9-8-18(33-22)12-19-15(3)25-26(23(19)28)17-6-4-16(5-7-17)24(29)30/h4-12H,1-3H3,(H,29,30)/b19-12-

InChI key

HEKJYZZSCQBJGB-UNOMPAQXSA-N

一般描述

一种可逆、细胞可渗透吡唑啉酮p300/CBP HAT抑制剂(Ki = 400 nM),可与乙酰辅酶A竞争p300 Lys-CoA结合袋。该化合物在10 nM处对p300有86%的抑制作用,但在化学筛选测定中对羟色胺N-乙酰转移酶、PCAF组蛋白乙酰转移酶、GCN5组蛋白乙酰转移酶、Rtt109组蛋白乙酰转移酶、Sas组蛋白乙酰转移酶以及MOZ组蛋白乙酰转移酶的抑制作用均小于10%。使用25µ M化合物处理C3H 10T1/2小鼠成纤维细胞可对组蛋白H3和H4的基础和TSA诱导乙酰化产生抑制效果。研究还表明,与25 µM基于多肽双底物p300/CBP HAT抑制剂Lys-CoA-Tat相比,10µM时可抑制黑色素瘤和非小细胞肺(NSCL)癌细胞系中人类细胞生长,并且具有相似或更高的药效。

包装

用惰性气体包装

制备说明

复溶后,分装并冷冻保存(-20°C。储备液在-20°C条件下可稳定保存3个月。

其他说明

Bowers, EM., et al. 2010.Chem Biol17, 471.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

毒性:标准处理(A)

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Kenji Ohshima et al.
The Journal of pathology, 256(2), 164-173 (2021-10-27)
Cancer cells have an altered metabolic state that supports their growth, for example, aerobic glycolysis, known as the Warburg effect. Colorectal cancer cells have been reported to exhibit the Warburg effect and mainly rely on glycolysis for progression and have
Virender Kumar Sharma et al.
Scientific reports, 11(1), 16427-16427 (2021-08-14)
Api5, is a known anti-apoptotic and nuclear protein that is responsible for inhibiting cell death in serum-starved conditions. The only known post-translational modification of Api5 is acetylation at lysine 251 (K251). K251 acetylation of Api5 is responsible for maintaining its
Lu Yang et al.
Communications biology, 4(1), 1373-1373 (2021-12-10)
Tumor suppressor p53, a critical regulator of cell fate, is frequently mutated in cancer. Mutation of p53 abolishes its tumor-suppressing functions or endows oncogenic functions. We recently found that p53 binds via its proline-rich domain to peptidase D (PEPD) and
Kee-Beom Kim et al.
Science advances, 8(7), eabl4618-eabl4618 (2022-02-17)
EP300, a transcription coactivator important in proliferation and differentiation, is frequently mutated in diverse cancer types, including small cell lung cancer (SCLC). While these mutations are thought to result in loss of EP300 function, the impact on tumorigenesis remains largely
Michael S Werner et al.
Nature communications, 14(1), 2095-2095 (2023-04-14)
Development can be altered to match phenotypes with the environment, and the genetic mechanisms that direct such alternative phenotypes are beginning to be elucidated. Yet, the rules that govern environmental sensitivity vs. invariant development, and potential epigenetic memory, remain unknown.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持